If you are thinking about doing some health economic analysis - you should consider using this approach promulgated by Pharmac. I will have a look myself and see what might be interesting, controversial or missing:
Wonder how of much of this is applied in benefits claim and cost savings for investments made?
opengraphobject:[360483084918784 : https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/cost-resource-manual/ : title=“Cost Resource Manual | PHARMAC” : description=“”]
I think that is the intent of Pharmac publishing these - to build a set of accepted figures that can be used consistently.
Of course the devil is in the detail, and I am interested in the assumptions and the sources of the information.
opengraphobject:[360483084918784 : https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/cost-resource-manual/ : title=“Cost Resource Manual | PHARMAC” : description=“”]